Replies to post #243302 on Amarin Corp Plc (AMRN)

[HDGabor]

s-

I expected an offer in Q1 2019 but I revised it (IRCC) in Q2 19 (or sometimes in 2019) as after FDA approval and Order.

Meanwhile a BO is not guaranteed I could not imagine that nobody interested in Vascepa (at least offer will be (was? but low) submitted).

I see Q2 2020 as a reasonable time for it … after the Order. (plus: Amarin will know the list of questions regarding EU submission … or - not likely - the Opinion / recommendation for approval by end of March.)

(i) Amarin win the litigation
(ii) (short) list of questions regarding EU submission … or Opinion

…

Best,
G